Bionano Genomics Inc. Insider Trading

BNGO

⊜ Compare

Last 12 months

Insiders bought 10K on the open market and sold nothing.

Net open-market

+10K

2 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Sep 2026

Sep 4, 2026

Get an email when BNGO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 4	Albert Luderer Interim Chief Executive	Bought	4,000	$1.21	5K	100%	Form 4
Aug 21	Albert Luderer Interim Chief Executive	Bought	4,000	$1.22	5K	New	Form 4

Sep 4
Albert Luderer
Interim Chief Executive · bought 4,000 at $1.21
5K
100% of stake
Aug 21
Albert Luderer
Interim Chief Executive · bought 4,000 at $1.22
5K
New position

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BNGO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Laboratory Analytical Instruments · Pick stocks to compare with BNGO

CompareIntrinsic value

PRPOPrecipio Inc.

$19.57+5.10%57

RPIDRapid Micro Biosystems, Inc.

$0.68-1.59%30

SEERSeer, Inc.

$1.70-1.73%35

LCTCLifeloc Technologies Inc.

$3.50+0.00%11

EYPTEyePoint Pharmaceuticals Inc.

$0.40+0.00%10

SCNDScientific Industries Inc.

$0.65+0.00%10

HBIOHarvard Bioscience, Inc.

$8.61-0.69%15

LABStandard Biotools Inc.

$0.62+1.38%35

Spot a number that looks wrong? Check it in BNGO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BNGO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.